2014
DOI: 10.1293/tox.2013-0033
|View full text |Cite
|
Sign up to set email alerts
|

Pathology and Neurotoxicity in Dogs after Repeat Dose Exposure to a Serotonin 5-HT<sub>1B</sub> Inhibitor

Abstract: AZD3783, a cationic amphiphilic drug and a potent inhibitor of the 5-hydroxytryptamine (5-HT1B) receptor, was explored as a potential treatment for depression. To support clinical trials, repeat dose toxicity studies in rats and dogs were conducted. Here we report toxicity findings in dogs after dosing from 1 to 3 months. In the 1-month study, there were minimal neuronal vacuolation in the brain, a marked increase in liver enzymes accompanied by hepatocellular degeneration/necrosis and phospholipidosis (PLD), … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 30 publications
(36 reference statements)
0
3
0
Order By: Relevance
“…Undesirable side effects have been reported with at least some related drugs. For example, AZD3783, a potent inhibitor of the 5‐HT1B receptor, was neurotoxic in dogs (60). Dox was found to be highly effective in our studies, but it also can evidence negative side effects (61), and whether a more selective α blocker would be safer but just as effective remains to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Undesirable side effects have been reported with at least some related drugs. For example, AZD3783, a potent inhibitor of the 5‐HT1B receptor, was neurotoxic in dogs (60). Dox was found to be highly effective in our studies, but it also can evidence negative side effects (61), and whether a more selective α blocker would be safer but just as effective remains to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Inhalation of poorly soluble test compounds can also result in the same type of response (Nikula et al 2013). Alveolar macrophage accumulation can also be induced by noninhalation administration of compounds which cause phospholipidosis (Mazue et al 1984;Chang et al 2014). In dog studies, interpretation of a marginal increase in the incidence and/or severity in dosed groups can be challenging because of the small group sizes used in toxicology studies.…”
Section: Discussionmentioning
confidence: 99%
“…The remainder of the presentation centered on phospholipidosis, which Halliwell (1997, 53) stated is “an excessive accumulation of intracellular phospholipids.” On histopathology, phospholipidosis can be suspected in cases of foamy cytoplasmic vacuolation in a wide variety of cells, with single or multiple tissue involvement (Halliwell 1997; Cartwright et al 2009; Chang et al 2014). Phospholipidosis may be subcategorized into “macrophage dominant,” “parenchymal cell dominant,” and “localized” (Ettlin et al 2010, 221).…”
Section: Canine and Rodent Pulmonary Pathology: Are They The Same Or Different? An Ultrastructural Case Studymentioning
confidence: 99%